Source: Eur Respir J, 50 (3) 1700196; 10.1183/13993003.00196-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Fricker, Peter G. Gibson. Macrophage dysfunction in the pathogenesis and treatment of asthma. Eur Respir J, 50 (3) 1700196; 10.1183/13993003.00196-2017

Member's Comments

No comment yet.

Related content which might interest you: Lysosomal dysfunction in COPD pathogenesis. Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Lymphocyte apoptosis in atopic bronchial asthma: the mechanisms, role in pathogenesis and therapy Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis Source: ERS Lung Science Conference 2021 Year: 2021 Severe asthma: from inflammatory phenotype to treatment Source: International Congress 2017 – Chinese Programme 2017 Year: 2017 Endothelial dysfunction and arterial rigidity in patients with bronchial asthma out of an exacerbation Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021 Year: 2022 Vascular dysfunction and systemic inflammation in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011 Systemic inflammation and endothelial dysfunction in patient with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Systemic inflammation and endothelial dysfunction in patient with bronchial asthma Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Role of necroptosis in the pathogenesis of COPD Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease Year: 2019 Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 The role of neutrophilic inflammation in asthma of different severity Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002